These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


182 related items for PubMed ID: 12018406

  • 1. The myotubularin family: novel phosphoinositide regulators.
    Nandurkar HH, Huysmans R.
    IUBMB Life; 2002 Jan; 53(1):37-43. PubMed ID: 12018406
    [Abstract] [Full Text] [Related]

  • 2. The structure and regulation of myotubularin phosphatases.
    Begley MJ, Dixon JE.
    Curr Opin Struct Biol; 2005 Dec; 15(6):614-20. PubMed ID: 16289848
    [Abstract] [Full Text] [Related]

  • 3. The myotubularin family: from genetic disease to phosphoinositide metabolism.
    Laporte J, Blondeau F, Buj-Bello A, Mandel JL.
    Trends Genet; 2001 Apr; 17(4):221-8. PubMed ID: 11275328
    [Abstract] [Full Text] [Related]

  • 4. Identification and localization of a new human myotubularin-related protein gene, mtmr8, on 8p22-p23.
    Appel S, Reichwald K, Zimmermann W, Reis A, Rosenthal A, Hennies HC.
    Genomics; 2001 Jul; 75(1-3):6-8. PubMed ID: 11472061
    [Abstract] [Full Text] [Related]

  • 5. Identification of myotubularin as the lipid phosphatase catalytic subunit associated with the 3-phosphatase adapter protein, 3-PAP.
    Nandurkar HH, Layton M, Laporte J, Selan C, Corcoran L, Caldwell KK, Mochizuki Y, Majerus PW, Mitchell CA.
    Proc Natl Acad Sci U S A; 2003 Jul 22; 100(15):8660-5. PubMed ID: 12847286
    [Abstract] [Full Text] [Related]

  • 6. Characterization of an adapter subunit to a phosphatidylinositol (3)P 3-phosphatase: identification of a myotubularin-related protein lacking catalytic activity.
    Nandurkar HH, Caldwell KK, Whisstock JC, Layton MJ, Gaudet EA, Norris FA, Majerus PW, Mitchell CA.
    Proc Natl Acad Sci U S A; 2001 Aug 14; 98(17):9499-504. PubMed ID: 11504939
    [Abstract] [Full Text] [Related]

  • 7. A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy.
    Tosch V, Rohde HM, Tronchère H, Zanoteli E, Monroy N, Kretz C, Dondaine N, Payrastre B, Mandel JL, Laporte J.
    Hum Mol Genet; 2006 Nov 01; 15(21):3098-106. PubMed ID: 17008356
    [Abstract] [Full Text] [Related]

  • 8. Crystal structure of a phosphoinositide phosphatase, MTMR2: insights into myotubular myopathy and Charcot-Marie-Tooth syndrome.
    Begley MJ, Taylor GS, Kim SA, Veine DM, Dixon JE, Stuckey JA.
    Mol Cell; 2003 Dec 01; 12(6):1391-402. PubMed ID: 14690594
    [Abstract] [Full Text] [Related]

  • 9. MTM1 mutations in X-linked myotubular myopathy.
    Laporte J, Biancalana V, Tanner SM, Kress W, Schneider V, Wallgren-Pettersson C, Herger F, Buj-Bello A, Blondeau F, Liechti-Gallati S, Mandel JL.
    Hum Mutat; 2000 Dec 01; 15(5):393-409. PubMed ID: 10790201
    [Abstract] [Full Text] [Related]

  • 10. Implication of phosphoinositide phosphatases in genetic diseases: the case of myotubularin.
    Tronchère H, Buj-Bello A, Mandel JL, Payrastre B.
    Cell Mol Life Sci; 2003 Oct 01; 60(10):2084-99. PubMed ID: 14618257
    [Abstract] [Full Text] [Related]

  • 11. Expression of myotubularin by an adenoviral vector demonstrates its function as a phosphatidylinositol 3-phosphate [PtdIns(3)P] phosphatase in muscle cell lines: involvement of PtdIns(3)P in insulin-stimulated glucose transport.
    Chaussade C, Pirola L, Bonnafous S, Blondeau F, Brenz-Verca S, Tronchère H, Portis F, Rusconi S, Payrastre B, Laporte J, Van Obberghen E.
    Mol Endocrinol; 2003 Dec 01; 17(12):2448-60. PubMed ID: 14500759
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Myotubularin phosphatases: policing 3-phosphoinositides.
    Robinson FL, Dixon JE.
    Trends Cell Biol; 2006 Aug 01; 16(8):403-12. PubMed ID: 16828287
    [Abstract] [Full Text] [Related]

  • 16. Interaction of the protein tyrosine phosphatase PTPL1 with the PtdIns(3,4)P2-binding adaptor protein TAPP1.
    Kimber WA, Deak M, Prescott AR, Alessi DR.
    Biochem J; 2003 Dec 01; 376(Pt 2):525-35. PubMed ID: 14516276
    [Abstract] [Full Text] [Related]

  • 17. X-linked myotubular myopathy: report of a case with novel mutation.
    Hortobágyi T, Szabó H, Kovács KS, Bódi I, Bereg E, Katona M, Biancalana V, Túri S, Sztriha L.
    J Child Neurol; 2007 Apr 01; 22(4):447-51. PubMed ID: 17621527
    [Abstract] [Full Text] [Related]

  • 18. Characterisation of mutations in 77 patients with X-linked myotubular myopathy, including a family with a very mild phenotype.
    Biancalana V, Caron O, Gallati S, Baas F, Kress W, Novelli G, D'Apice MR, Lagier-Tourenne C, Buj-Bello A, Romero NB, Mandel JL.
    Hum Genet; 2003 Feb 01; 112(2):135-42. PubMed ID: 12522554
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Myotubularin and MTMR2, phosphatidylinositol 3-phosphatases mutated in myotubular myopathy and type 4B Charcot-Marie-Tooth disease.
    Kim SA, Taylor GS, Torgersen KM, Dixon JE.
    J Biol Chem; 2002 Feb 08; 277(6):4526-31. PubMed ID: 11733541
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.